Should patients exhibiting symptoms of well-defined genetic diseases have different rights than patients with the same symptoms due to less-understood conditions? Should expensive genetic-based therapies be available to those who have many other options for treatment? This module explores patient care and rights in the new age of ubiquitous genetic therapies and genetic knowledge.
![]() |
![]() |
![]() |
|||||||||||
![]() |
![]() |
||||||||||||
![]() |
![]() |
||||||||||||
![]() |
![]() |
||||||||||||
![]() |
![]() |
||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |


















